Related Experiment Videos
[Gutron studied as an agent for preventing radiation lesions]
Radiatsionnaia Biologiia, Radioecologiia
|March 1, 1997
Summary
Gutron, an alpha-adrenomimetic drug, demonstrated significant radioprotective effects in male mice exposed to radiation. Optimal protection was achieved when Gutron was administered at specific intervals before irradiation, enhancing animal survival rates.
Area of Science:
- Radiation biology
- Pharmacology
- Mathematical modeling
Context:
- Radiation exposure poses significant health risks.
- Alpha-adrenomimetic drugs are being investigated for therapeutic potential.
- CBA male mice were used as a model organism.
Purpose:
- To investigate the radioprotective effect of Gutron.
- To determine the optimal administration timing and dosage of Gutron.
- To evaluate the efficacy of Gutron in enhancing survival rates after radiation exposure.
Summary:
- Gutron (an alpha-adrenomimetic) was administered to mice at doses of 1-5 mg/kg.
- Administration occurred 10-40 min and 1-4 h prior to irradiation (6-7.5 Gy).
- Mathematical modeling was employed to analyze the radioprotective effect and optimize Gutron usage.
Impact:
- Gutron demonstrated a significant radioprotective effect in mice.
- Protection coefficients (s) ranged from 0.4 to 0.7, indicating enhanced survival.
- Findings suggest Gutron's potential as a radioprotective agent.